Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The trial duration was 36 weeks
For patients using GLP-1 medications for type 2 diabetes, hemoglobin A1c may increase after discontinuation if no alternative therapy is initiated, with the magnitude varying based on individual factors and baseline therapy
We've listed them below, starting with firms with approved drugs
BMJ 363:k4365
Current GLP-1RAs include human GLP-1 analogs (e.g., liraglutide, dulaglutide, semaglutide) and exendin-4derived peptides (e.g., exenatide, lixisenatide), each modified to extend half-life through various mechanisms such as amino acid substitution and lipidation (14)
MCP-1, Monocyte chemoattractant protein-1
US$ 20.29
US$ 20.06
US$ 24.90
US$ 20.87
US$ 22.45
